Standout Papers

Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial 2023 2026 202462
  1. Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial (2023)
    Hamdi Jama, Michael Nakai et al. Nature Cardiovascular Research

Immediate Impact

57 standout
Sub-graph 1 of 22

Citing Papers

Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
Immune and inflammatory mechanisms in hypertension
2024 Standout
2 intermediate papers

Works of Yusuke Sata being referenced

Prebiotic intervention with HAMSAB in untreated essential hypertensive patients assessed in a phase II randomized trial
2023 Standout
Renal denervation: current implications and future perspectives
2013
and 1 more

Author Peers

Author Last Decade Papers Cites
Yusuke Sata 588 156 153 185 171 51 990
Gianmaria Brambilla 1075 150 146 108 212 57 1.4k
Manja Reimann 313 120 125 203 128 44 1.1k
Gianluca E.M. Boari 802 118 208 130 230 46 1.3k
Gilbert R. Hageman 839 115 251 311 158 61 1.4k
Barbara L. Pegram 736 103 239 227 132 56 1.2k
Carolyn J. Barrett 816 106 182 134 133 68 1.3k
Revathy Carnagarin 428 75 160 220 216 84 1.1k
Atsuhiro Yoshida 312 155 59 130 173 75 982
Piyush Jain 347 37 171 181 133 37 1.1k
Matthew J. Durand 479 47 346 276 144 44 1.2k

All Works

Loading papers...

Rankless by CCL
2026